Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
67%(6 trials)

Phase Distribution

Ph phase_1
3
33%
Ph phase_3
3
33%
Ph phase_2
3
33%

Phase Distribution

3

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 23 (33.3%)
Phase 33 (33.3%)

Trials by Status

completed9100%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

NCT02512510
completedphase_1

TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

NCT02772159
completedphase_2

A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

NCT02040792
completedphase_2

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

NCT01704404
completedphase_3

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

NCT02459080
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02512510Phase 3

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02772159Phase 1

TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

Completed
NCT02040792Phase 2

A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT01704404Phase 2

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

Completed
NCT02459080Phase 3

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02518139Phase 3

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02109172Phase 2

A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02578082Phase 1

Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment

Completed
NCT02581592Phase 1

Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9